Biomarkers in COPD - Do we need them?;Biomarkery w POChP - Czy sa nam potrzebne?

Pneumonologia i Alergologia Polska

Volumn 79, Issue 2, 2011, Pages 144-150

  Batura Gabryel, Halina ^a  

^a Onkologii Pulmonologicznej Uniwersytetu Medycznego   (Poland)

Author keywords

Biomarkers; COPD; Phenotypes

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; GENETICS; HUMAN; PHENOTYPE;

BIOLOGICAL MARKERS; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79952356613     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Batura-Gabryel H. POChP jako choroba systemowa. Terapia 2010; 9 (245): 6-11.
2. http://www.goldcopd.com
3. Augusti A.G.N. COPD, a multicomponent disease: implications for management. Respir. Med. 2005; 99: 670-682.
4. Batura-Gabryel H. Zmiany ogólnoustrojowe u chorych na POChP. Pneumonol. Alergol. Pol. 2009; 77: 180-185.
5. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Complex chronic comorbidities of COPD. Eur. Respir. J. 2008; 31: 204-212.
6. Cazzola M., MacNee W., Martinez F.J. i wsp. ATS/ERS TASK FORCE: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J. 2008; 31: 416- -469
7. Sin D., Vestbo J. Biomarkers in chronic obstructive pulmonary disease. Amer. Thorac. Soc. 2009; 6: 543-545.
8. Barnes P.J., Chowdhury B., Kharitonov S.A. i wsp. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 174: 6-14. (Pubitemid 43955238)
9. Singh D., Edwards L., Tal-Singer R., Rennard S. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study Respir. Res. 2010; 11: 77.
10. Lacoma A., Prat C., Andreo F., Domínguez J. Biomarkers in the management of COPD. Eur. Resp. Rev. 2009; 18: 96-104.
11. Sin D.D., Man S.F.P. Biomarkers in COPD: are we there yet? Chest 2008; 133: 1296-1298. (Pubitemid 351892982)
12. Perera W. R., Hurst J., Wilkinson R.T.M.A. i wsp. Inflammatory changes recovery and recurrence At COPD exacerbation. Eur. Resp. J. 2007; 29: 527-534. (Pubitemid 46372101)
13. Cheng N., Tian Je., Ye P.P., Ye R.D. Cutting edge: TLR-2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008; 181: 22-26.
14. Celli B.R., Cote C.G., Marin J.M. i wsp. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005-1012. (Pubitemid 38269277)
15. Groenewegen K.H., Schols A.M., Wouters E.F. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467. (Pubitemid 37000120)
16. Soler-Cataluna J.J., Martinez-Garcia M.A., Roman Sanchez P. i wsp. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931. (Pubitemid 41598207)
17. Anthonisen N.R., Soriano J.B. i wsp. Mortality in COPD: role of comorbidities. Eur. Respir. J. 2006; 28: 1245-1257. (Pubitemid 44883863)
18. Sevenoaks M.J., Stockley R.A. Chronic obstructive pulmonary disease, inflammation and co-morbidity - a common inflammatory phenotype? Respir. Res. 2006; 7: 70-77.
19. de Torres J.P., Pinto-Plata V., Casanova C. i wsp. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008; 133: 1336-1343. (Pubitemid 351892988)
20. Berdowska A., Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J. Clin. Pharm. Ther. 2001; 26: 319-329. (Pubitemid 32989554)
21. Han M.K., Agusti A., Calverley P.M. i wsp. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Am. J. Respir. Crit. Care Med. 2010; 182: 598-604.
22. Roy K., Smith J., Kolsum U., Borrill Z., Vestbo J., Singh D. COPD phenotype description using principal components analysis. Respir. Res. 2009; 10: 41.
23. Eagan T.M.L., Ueland T., Wagner P.D. i wsp. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Eagan TML et al. Eur. Respir. J. 2010; 35: 540-548.
24. Lomas D.A., Silverman E.K., Edwards L.D. i wsp. Protein biomarkers. Eur. Respir. J. 2009; 34: 95-102.
25. Vestbo J.; on behalf of the ECLIPSE Steering Committee, Scientific Committee and Investigators. Phenotypes and biomarkers: Initial 3-year findings from the ECLIPSE Study 20th ERS Annual Congress, Barcelona 2010, abstract 5695.